Parvoviruses are inefficient in inducing interferon-beta, tumor necrosis factor-alpha, or interleukin-6 in mammalian cells
- PMID: 1522825
- DOI: 10.1007/BF00202055
Parvoviruses are inefficient in inducing interferon-beta, tumor necrosis factor-alpha, or interleukin-6 in mammalian cells
Abstract
To investigate a possible role of cytokines in parvovirus-mediated suppression of tumorigenesis, we tested in cell culture whether parvoviruses are able to induce interferon (IFN)-beta, tumor necrosis factor (TNF)-alpha or interleukin-6 (IL-6). Infection of rodent or human cells with the parvoviruses minute virus of mice (MVM), H-1 or adeno-associated virus (AAV) types 2 or 5 failed to induce expression of the luciferase or beta-galactosidase reporter genes transfected into these cells as constructs containing an IFN-beta promoter. Parvoviruses did weakly induce synthesis of TNF-alpha and of IL-6 in cell culture and could slightly enhance synthesis of these cytokines when induced by other agents. These in vitro data suggest that the rather unspecific tumor-suppressive properties of parvoviruses are unlikely to be attributable to stimulation of the synthesis of IFN, TNF or IL-6.
Similar articles
-
Rapid acquisition of an enhanced capacity to produce tumor necrosis factor, alpha/beta interferon, and interleukin 6 after implantation of tumor cells.Cytokine. 1991 Sep;3(5):398-406. doi: 10.1016/1043-4666(91)90043-d. Cytokine. 1991. PMID: 1751777
-
Autonomous parvoviruses neither stimulate nor are inhibited by the type I interferon response in human normal or cancer cells.J Virol. 2014 May;88(9):4932-42. doi: 10.1128/JVI.03508-13. Epub 2014 Feb 19. J Virol. 2014. PMID: 24554651 Free PMC article.
-
Analysis of cytokine production in a newly developed canine tracheal epithelial cell line infected with H3N2 canine influenza virus.Arch Virol. 2015 Jun;160(6):1397-405. doi: 10.1007/s00705-015-2395-1. Epub 2015 Mar 24. Arch Virol. 2015. PMID: 25797195
-
Induction of an embryonic mouse innate immune response following inoculation in utero with minute virus of mice.J Virol. 2015 Feb;89(4):2182-91. doi: 10.1128/JVI.02908-14. Epub 2014 Dec 3. J Virol. 2015. PMID: 25473047 Free PMC article.
-
Synergistic interactions of interleukin 1, interferon-beta, and tumor necrosis factor in terminally differentiating a mouse myeloid leukemic cell line (M1). Evidence that interferon-beta is an autocrine differentiating factor.J Immunol. 1988 Jan 1;140(1):112-9. J Immunol. 1988. PMID: 3275716
Cited by
-
Human Retrotransposons and the Global Shutdown of Homeostatic Innate Immunity by Oncolytic Parvovirus H-1PV in Pancreatic Cancer.Viruses. 2021 May 28;13(6):1019. doi: 10.3390/v13061019. Viruses. 2021. PMID: 34071585 Free PMC article.
-
Parvovirus evades interferon-dependent viral control in primary mouse embryonic fibroblasts.Virology. 2013 Jul 20;442(1):20-7. doi: 10.1016/j.virol.2013.03.020. Epub 2013 May 12. Virology. 2013. PMID: 23676303 Free PMC article.
-
TLR-9 contributes to the antiviral innate immune sensing of rodent parvoviruses MVMp and H-1PV by normal human immune cells.PLoS One. 2013;8(1):e55086. doi: 10.1371/journal.pone.0055086. Epub 2013 Jan 29. PLoS One. 2013. PMID: 23383065 Free PMC article.
-
Novel mutation N588 residue in the NS1 protein of feline parvovirus greatly augments viral replication.J Virol. 2024 May 14;98(5):e0009324. doi: 10.1128/jvi.00093-24. Epub 2024 Apr 9. J Virol. 2024. PMID: 38591899 Free PMC article.
-
Immune Conversion of Tumor Microenvironment by Oncolytic Viruses: The Protoparvovirus H-1PV Case Study.Front Immunol. 2019 Aug 7;10:1848. doi: 10.3389/fimmu.2019.01848. eCollection 2019. Front Immunol. 2019. PMID: 31440242 Free PMC article. Review.